Genus (LON:GNS - Get Free Report) posted its earnings results on Thursday. The company reported GBX 39.80 ($0.51) EPS for the quarter, Digital Look Earnings reports. Genus had a return on equity of 1.41% and a net margin of 1.18%.
Genus Stock Performance
LON:GNS traded up GBX 2.66 ($0.03) during trading hours on Monday, reaching GBX 1,828.82 ($23.24). 268,720 shares of the company's stock were exchanged, compared to its average volume of 136,445. Genus has a 1-year low of GBX 1,424 ($18.10) and a 1-year high of GBX 2,155 ($27.39). The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The firm has a market capitalization of £1.20 billion, a price-to-earnings ratio of 151.59, a P/E/G ratio of 2.87 and a beta of 0.37. The company has a 50-day moving average of GBX 1,715.47 and a 200 day moving average of GBX 1,799.09.
Wall Street Analysts Forecast Growth
Separately, Shore Capital reaffirmed a "buy" rating on shares of Genus in a research report on Wednesday, December 11th.
Read Our Latest Report on Genus
Insider Buying and Selling at Genus
In other news, insider Jorgen Kokke sold 19,967 shares of Genus stock in a transaction dated Friday, February 28th. The shares were sold at an average price of GBX 1,731 ($22.00), for a total value of £345,628.77 ($439,228.33). 0.75% of the stock is currently owned by company insiders.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Read More
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.